Shares of Viking Therapeutics ( NASDAQ: VKTX ) jumped 22% Monday morning after the biotech firm reported promising results for its experimental obesity pill, with increased weight loss observed at higher doses. Patients on 100-milligram doses of Viking’s ( VKTX ) VK2735 lost an.
Back to Health Page
